Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO12323 | Bos taurus | Species | Bovidae | Eukaryota | HerDing* | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | DOI[10.1038/nbt.2488] | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine |
PMID[7256725] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | saliva |
PMID[15179829] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood |
PMID[10731506] |
||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[19425150] |
|||
NPO12323 | Bos taurus | Species | Bovidae | Eukaryota | TCMID* | |||
NPO17393 | Bubalus bubalis | Species | Bovidae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Kd | = | 0.1 | nM | 12109914 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Kd | = | 0.1 | nM | 12109914 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | EC50 | = | 2 | nM | 12109914 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | EC50 | = | 2 | nM | 12109914 |
NPT5683 | Individual Protein | Thyroid hormone receptor beta-1 | Rattus norvegicus | IC50 | = | 4.4 | nM | 7861417 |
NPT5683 | Individual Protein | Thyroid hormone receptor beta-1 | Rattus norvegicus | IC50 | = | 500 | nM | 7861417 |
NPT5683 | Individual Protein | Thyroid hormone receptor beta-1 | Rattus norvegicus | IC50 | = | 1.8 | nM | 7861417 |
NPT5683 | Individual Protein | Thyroid hormone receptor beta-1 | Rattus norvegicus | IC50 | = | 100 | nM | 7861417 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 0.1 | mg/kg | 7861417 |
NPT4323 | Individual Protein | Transthyretin | Rattus norvegicus | Ratio | = | 0.05 | 3100800 | |
NPT5121 | Protein Complex | Thyroid hormone receptor | Homo sapiens | Ratio | = | 0.01 | 3100800 | |
NPT805 | Protein Complex | GABA-A receptor; anion channel | Rattus norvegicus | EC50 | = | 7000 | nM | 10780899 |
NPT996 | Protein Complex | GABA-A receptor; anion channel | Homo sapiens | IC50 | = | 23000 | nM | 10780899 |
NPT2 | Others | Unspecified | Activity | = | 100 | % | 7381861 | |
NPT5122 | Individual Protein | Thyroxine-binding globulin | Homo sapiens | Activity | = | 9 | % | 7381861 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Kd | = | 0.17 | nM | 11597408 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Kd | = | 0.14 | nM | 11597408 |
NPT2 | Others | Unspecified | Ki | = | 1.56 | nM | 1738147 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 251 | 1738147 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 138 | 1738147 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 101 | 1738147 | |
NPT2 | Others | Unspecified | IC50 | = | 1.1 | nM | 10937719 | |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Ki | = | 0.08 | nM | 12565933 |
NPT5121 | Protein Complex | Thyroid hormone receptor | Homo sapiens | Ratio | = | 0.8 | 12565933 | |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | EC50 | = | 2 | nM | 12565933 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | EC50 | = | 2 | nM | 12565933 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Kd | = | 0.06 | nM | 12825953 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Kd | = | 0.087 | nM | 12825953 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | IC50 | = | 0.24 | nM | 16099653 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | IC50 | = | 0.26 | nM | 16099653 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED15 | = | 31 | nmol/kg/day | 17543524 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | IC50 | = | 0.24 | nM | 17543524 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | IC50 | = | 0.26 | nM | 17543524 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 0.54 | 17543524 | ||
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 21 | nmol/kg/day | 17543524 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 1.5 | 17543524 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED30 | = | 6.7 | nmol/kg/day | 17543524 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 0.3 | 17543524 | |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | IC50 | = | 0.257 | nM | 17524652 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Kd | = | 0.058 | nM | 17988877 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Kd | = | 0.081 | nM | 17988877 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | EC50 | = | 2.4 | nM | 17988877 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | EC50 | = | 11 | nM | 17988877 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | EC50 | = | 2.4 | nM | 17988877 |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Inhibition | = | 24 | % | 17911242 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | FC | = | 6.644 | 17878314 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.001365 | 17878314 | |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Ki | = | 0.22 | nM | 17878314 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Ki | = | 0.55 | nM | 17878314 |
NPT2 | Others | Unspecified | Ratio Ki | = | 0.4 | 17878314 | ||
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 0.012 | mg/kg | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.14 | 17878314 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.0139 | 17878314 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.49 | ug/ml | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 37.3 | ug/ml | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.57 | 17878314 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.93 | 17878314 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.42 | ug/ml | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 4.2 | ug/ml | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 4.06 | ug/ml | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 1.43 | ug/ml | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.0031 | 17878314 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.0978 | 17878314 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 16.45 | ug/ml | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 8.4 | ug/ml | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.081 | 17878314 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 4.3 | ug | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 16.2 | % | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 25 | mg/dl | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.937 | nM | 17878314 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.334 | ug/ml | 17878314 |
NPT32 | Organism | Mus musculus | Mus musculus | FC | = | 2.04 | 17878314 | |
NPT32 | Organism | Mus musculus | Mus musculus | FC | = | 1.39 | 17878314 | |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | -42.4 | % | 17878314 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 9.5 | % | 17878314 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Ki | = | 0.33 | nM | 18975928 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Ki | = | 0.68 | nM | 18975928 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 7.52 | U/min | 18975928 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 4.18 | U/min | 18975928 |
NPT1416 | Individual Protein | Neuropeptide S receptor | Homo sapiens | Potency | = | 794.3 | nM | PubChem BioAssay data set |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 2818.4 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 7943.3 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | = | 0.38 | nM | 20875743 | |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1636 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8199.5 | nM | PubChem BioAssay data set | ||
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | 7943.3 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 19011.5 | nM | PubChem BioAssay data set | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Potency | 891.3 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 13459.1 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT901 | Individual Protein | UDP-glucuronosyltransferase 1-1 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT703 | Individual Protein | UDP-glucuronosyltransferase 1-9 | Homo sapiens | Activity | = | 100 | pm/min/mg | 10836148 |
NPT702 | Individual Protein | UDP-glucuronosyltransferase 1-6 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT703 | Individual Protein | UDP-glucuronosyltransferase 1-9 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT902 | Individual Protein | UDP-glucuronosyltransferase 1A4 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT704 | Individual Protein | UDP-glucuronosyltransferase 2B15 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT216 | Individual Protein | Adenosine A1 receptor | Homo sapiens | IC50 | = | 410.9 | nM | DrugMatrix in vitro pharmacology data |
NPT216 | Individual Protein | Adenosine A1 receptor | Homo sapiens | Ki | = | 239.7 | nM | DrugMatrix in vitro pharmacology data |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | IC50 | > | 50000 | nM | 22047606 |
NPT445 | Individual Protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | 11423.9 | nM | PubChem BioAssay data set | |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Ki | = | 2.29 | nM | 22542282 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Ki | = | 2.33 | nM | 22542282 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Activity | = | 100 | % | 22542282 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Activity | = | 100 | % | 22542282 |
NPT2 | Others | Unspecified | Ratio Ki | = | 1 | 22542282 | ||
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 0.00595 | umol/kg | 22542282 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED30 | = | 1.87 | nmol/Kg | 22542282 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 0.31 | 22542282 | |
NPT1154 | Individual Protein | Monocarboxylate transporter 8 | Rattus norvegicus | Activity | = | 62 | % | 12871948 |
NPT877 | Individual Protein | Solute carrier family 22 member 8 | Mus musculus | Activity | = | 39.8 | % | 14762099 |
NPT1154 | Individual Protein | Monocarboxylate transporter 8 | Rattus norvegicus | Activity | = | 57 | % | 12871948 |
NPT305 | Individual Protein | Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus | IC50 | = | 50400 | nM | 11561088 |
NPT1744 | Individual Protein | Solute carrier organic anion transporter family member 1C1 | Mus musculus | Ki | = | 24200 | nM | 15166123 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 33498.3 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 103.2 | nM | PubChem BioAssay data set | |
NPT155 | Individual Protein | Aryl hydrocarbon receptor | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 48557.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2511.9 | nM | PubChem BioAssay data set | ||
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Ratio Ki | = | 1 | 23276448 | ||
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Activity | = | 100 | % | 23276448 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Activity | = | 100 | % | 23276448 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Ki | = | 2.29 | nM | 23276448 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Ki | = | 2.33 | nM | 23276448 |
NPT5123 | Individual Protein | Proliferating cell nuclear antigen | Homo sapiens | IC50 | = | 3600 | nM | 23395113 |
NPT2 | Others | Unspecified | Potency | 21136 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29855.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Ki | = | 0.018 | nM | 23403082 | |
NPT2 | Others | Unspecified | IC50 | = | 0.034 | nM | 23403082 | |
NPT2 | Others | Unspecified | Inhibition | = | 6 | % | 23403082 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 31 | ng/dl | 24290064 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.9 | ug/dl | 24290064 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.1 | uIU/ml | 24290064 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 1.25 | ug | 24290064 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 430 | bpm | 24290064 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 61 | mg/dl | 24290064 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 22 | mg/dl | 24290064 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 28 | mg/dl | 24290064 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 123 | mg/dl | 24290064 |
NPT2 | Others | Unspecified | Ratio EC50 | = | 1 | 24290064 | ||
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | EC50 | = | 2 | nM | 24290064 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | EC50 | = | 2.1 | nM | 24290064 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.1 | 24290064 | ||
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | IC50 | = | 2.9 | nM | 24290064 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | IC50 | = | 3.2 | nM | 24290064 |
NPT2 | Others | Unspecified | Potency | 37141.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29849.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9511.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 33491.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1258.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 371.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23710.1 | nM | PubChem BioAssay data set | ||
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 23434.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5308 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26603.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 16735.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26524.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8485.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23914.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2.1 | nM | PubChem BioAssay data set | ||
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | EC50 | = | 10 | nM | 24712661 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | EC50 | = | 15 | nM | 24712661 |
NPT2 | Others | Unspecified | Ratio EC50 | = | 1 | 24712661 | ||
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Activity | = | 100 | % | 24712661 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | Activity | = | 100 | % | 24712661 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 10 | % | 24712661 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 545 | % | 818381 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 100 | % | 195056 |
NPT5682 | Individual Protein | Thyroid hormone receptor alpha | Homo sapiens | EC50 | = | 0.41 | nM | 25305688 |
NPT2 | Others | Unspecified | AC50 | 4470 | nM | PubChem BioAssay data set | ||
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | 666.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 562.3 | nM | PubChem BioAssay data set | ||
NPT32 | Organism | Mus musculus | Mus musculus | FC | = | 1.4 | 27381084 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC282087 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC318028 |
1.0 | High Similarity | NPC317741 |
1.0 | High Similarity | NPC328137 |
1.0 | High Similarity | NPC259800 |
1.0 | High Similarity | NPC318984 |
1.0 | High Similarity | NPC241086 |
0.9847 | High Similarity | NPC326860 |
0.9847 | High Similarity | NPC197239 |
0.8692 | High Similarity | NPC318357 |
0.8601 | High Similarity | NPC17760 |
0.8538 | High Similarity | NPC239697 |
0.8462 | Intermediate Similarity | NPC317784 |
0.8462 | Intermediate Similarity | NPC142638 |
0.8308 | Intermediate Similarity | NPC188867 |
0.8308 | Intermediate Similarity | NPC281686 |
0.8308 | Intermediate Similarity | NPC106551 |
0.8143 | Intermediate Similarity | NPC470392 |
0.8069 | Intermediate Similarity | NPC66518 |
0.8058 | Intermediate Similarity | NPC325651 |
0.7955 | Intermediate Similarity | NPC51345 |
0.7941 | Intermediate Similarity | NPC27581 |
0.7868 | Intermediate Similarity | NPC326079 |
0.7842 | Intermediate Similarity | NPC124776 |
0.7737 | Intermediate Similarity | NPC56634 |
0.773 | Intermediate Similarity | NPC145888 |
0.773 | Intermediate Similarity | NPC161593 |
0.773 | Intermediate Similarity | NPC16031 |
0.7721 | Intermediate Similarity | NPC319950 |
0.7721 | Intermediate Similarity | NPC264976 |
0.7692 | Intermediate Similarity | NPC45191 |
0.7692 | Intermediate Similarity | NPC326966 |
0.7681 | Intermediate Similarity | NPC142577 |
0.7677 | Intermediate Similarity | NPC56635 |
0.7639 | Intermediate Similarity | NPC88667 |
0.7537 | Intermediate Similarity | NPC26524 |
0.7448 | Intermediate Similarity | NPC48909 |
0.7424 | Intermediate Similarity | NPC97811 |
0.7413 | Intermediate Similarity | NPC476353 |
0.7397 | Intermediate Similarity | NPC244866 |
0.7394 | Intermediate Similarity | NPC89630 |
0.7379 | Intermediate Similarity | NPC241354 |
0.7368 | Intermediate Similarity | NPC234639 |
0.7368 | Intermediate Similarity | NPC259554 |
0.7361 | Intermediate Similarity | NPC296712 |
0.7347 | Intermediate Similarity | NPC307289 |
0.7338 | Intermediate Similarity | NPC132771 |
0.7299 | Intermediate Similarity | NPC296526 |
0.7297 | Intermediate Similarity | NPC470441 |
0.7292 | Intermediate Similarity | NPC321561 |
0.7266 | Intermediate Similarity | NPC471033 |
0.7266 | Intermediate Similarity | NPC311091 |
0.7248 | Intermediate Similarity | NPC6913 |
0.7246 | Intermediate Similarity | NPC19290 |
0.7246 | Intermediate Similarity | NPC128249 |
0.7237 | Intermediate Similarity | NPC204546 |
0.7222 | Intermediate Similarity | NPC158900 |
0.7197 | Intermediate Similarity | NPC42383 |
0.7192 | Intermediate Similarity | NPC2596 |
0.7192 | Intermediate Similarity | NPC478147 |
0.7178 | Intermediate Similarity | NPC314725 |
0.7178 | Intermediate Similarity | NPC313375 |
0.7163 | Intermediate Similarity | NPC263835 |
0.7163 | Intermediate Similarity | NPC474874 |
0.7153 | Intermediate Similarity | NPC109241 |
0.7152 | Intermediate Similarity | NPC223616 |
0.7143 | Intermediate Similarity | NPC1065 |
0.7132 | Intermediate Similarity | NPC266932 |
0.7132 | Intermediate Similarity | NPC233238 |
0.7125 | Intermediate Similarity | NPC207675 |
0.7125 | Intermediate Similarity | NPC212699 |
0.7111 | Intermediate Similarity | NPC79543 |
0.7105 | Intermediate Similarity | NPC40321 |
0.7103 | Intermediate Similarity | NPC3221 |
0.7103 | Intermediate Similarity | NPC88403 |
0.7093 | Intermediate Similarity | NPC235194 |
0.7092 | Intermediate Similarity | NPC43275 |
0.7083 | Intermediate Similarity | NPC140359 |
0.7083 | Intermediate Similarity | NPC13020 |
0.708 | Intermediate Similarity | NPC17693 |
0.7077 | Intermediate Similarity | NPC245561 |
0.7077 | Intermediate Similarity | NPC125732 |
0.7075 | Intermediate Similarity | NPC226661 |
0.7063 | Intermediate Similarity | NPC474862 |
0.7063 | Intermediate Similarity | NPC177291 |
0.7063 | Intermediate Similarity | NPC194416 |
0.7055 | Intermediate Similarity | NPC474476 |
0.7055 | Intermediate Similarity | NPC475236 |
0.7047 | Intermediate Similarity | NPC141549 |
0.7039 | Intermediate Similarity | NPC48202 |
0.7034 | Intermediate Similarity | NPC474237 |
0.7029 | Intermediate Similarity | NPC309808 |
0.7023 | Intermediate Similarity | NPC52472 |
0.7021 | Intermediate Similarity | NPC205502 |
0.7021 | Intermediate Similarity | NPC293424 |
0.7014 | Intermediate Similarity | NPC291189 |
0.7014 | Intermediate Similarity | NPC69403 |
0.7013 | Intermediate Similarity | NPC13696 |
0.7013 | Intermediate Similarity | NPC79372 |
0.7007 | Intermediate Similarity | NPC95034 |
0.7007 | Intermediate Similarity | NPC142087 |
0.7007 | Intermediate Similarity | NPC21890 |
0.7007 | Intermediate Similarity | NPC22783 |
0.7 | Intermediate Similarity | NPC243404 |
0.7 | Intermediate Similarity | NPC163398 |
0.6986 | Remote Similarity | NPC168259 |
0.6986 | Remote Similarity | NPC320242 |
0.6986 | Remote Similarity | NPC4164 |
0.6986 | Remote Similarity | NPC280767 |
0.6985 | Remote Similarity | NPC145638 |
0.6985 | Remote Similarity | NPC290566 |
0.698 | Remote Similarity | NPC257390 |
0.698 | Remote Similarity | NPC7569 |
0.698 | Remote Similarity | NPC326599 |
0.698 | Remote Similarity | NPC329595 |
0.698 | Remote Similarity | NPC278787 |
0.698 | Remote Similarity | NPC475102 |
0.698 | Remote Similarity | NPC2989 |
0.6978 | Remote Similarity | NPC235250 |
0.6975 | Remote Similarity | NPC319320 |
0.6975 | Remote Similarity | NPC287757 |
0.697 | Remote Similarity | NPC307425 |
0.6968 | Remote Similarity | NPC310370 |
0.6968 | Remote Similarity | NPC183642 |
0.6966 | Remote Similarity | NPC328267 |
0.6966 | Remote Similarity | NPC473942 |
0.6963 | Remote Similarity | NPC186469 |
0.6962 | Remote Similarity | NPC324081 |
0.6959 | Remote Similarity | NPC201419 |
0.6948 | Remote Similarity | NPC91953 |
0.6943 | Remote Similarity | NPC9373 |
0.6943 | Remote Similarity | NPC313414 |
0.694 | Remote Similarity | NPC473855 |
0.694 | Remote Similarity | NPC13495 |
0.6939 | Remote Similarity | NPC218323 |
0.6934 | Remote Similarity | NPC183700 |
0.6929 | Remote Similarity | NPC301321 |
0.6923 | Remote Similarity | NPC10781 |
0.6923 | Remote Similarity | NPC122493 |
0.6923 | Remote Similarity | NPC14177 |
0.6923 | Remote Similarity | NPC293628 |
0.6918 | Remote Similarity | NPC95733 |
0.6918 | Remote Similarity | NPC111088 |
0.6918 | Remote Similarity | NPC62101 |
0.6918 | Remote Similarity | NPC221798 |
0.6918 | Remote Similarity | NPC193805 |
0.6918 | Remote Similarity | NPC229113 |
0.6917 | Remote Similarity | NPC298224 |
0.6913 | Remote Similarity | NPC238309 |
0.6913 | Remote Similarity | NPC473019 |
0.6912 | Remote Similarity | NPC206341 |
0.6912 | Remote Similarity | NPC31274 |
0.6908 | Remote Similarity | NPC6570 |
0.6908 | Remote Similarity | NPC176814 |
0.6908 | Remote Similarity | NPC4982 |
0.6908 | Remote Similarity | NPC5310 |
0.6908 | Remote Similarity | NPC68779 |
0.6908 | Remote Similarity | NPC300776 |
0.6897 | Remote Similarity | NPC311219 |
0.6897 | Remote Similarity | NPC302211 |
0.6894 | Remote Similarity | NPC107101 |
0.6889 | Remote Similarity | NPC188677 |
0.6889 | Remote Similarity | NPC113457 |
0.6889 | Remote Similarity | NPC70843 |
0.6887 | Remote Similarity | NPC113006 |
0.6887 | Remote Similarity | NPC169766 |
0.6883 | Remote Similarity | NPC197921 |
0.6879 | Remote Similarity | NPC470860 |
0.6879 | Remote Similarity | NPC33717 |
0.6875 | Remote Similarity | NPC139839 |
0.6871 | Remote Similarity | NPC257589 |
0.6871 | Remote Similarity | NPC53305 |
0.6871 | Remote Similarity | NPC29477 |
0.6867 | Remote Similarity | NPC109778 |
0.6867 | Remote Similarity | NPC275538 |
0.6866 | Remote Similarity | NPC38209 |
0.6866 | Remote Similarity | NPC8931 |
0.6866 | Remote Similarity | NPC261573 |
0.6866 | Remote Similarity | NPC283546 |
0.6866 | Remote Similarity | NPC120693 |
0.6863 | Remote Similarity | NPC476018 |
0.6863 | Remote Similarity | NPC113295 |
0.6863 | Remote Similarity | NPC248872 |
0.6863 | Remote Similarity | NPC475029 |
0.6863 | Remote Similarity | NPC475011 |
0.6859 | Remote Similarity | NPC170812 |
0.6859 | Remote Similarity | NPC326065 |
0.6853 | Remote Similarity | NPC61779 |
0.6853 | Remote Similarity | NPC283760 |
0.6849 | Remote Similarity | NPC93730 |
0.6849 | Remote Similarity | NPC248786 |
0.6849 | Remote Similarity | NPC211218 |
0.6849 | Remote Similarity | NPC14141 |
0.6846 | Remote Similarity | NPC2401 |
0.6842 | Remote Similarity | NPC287533 |
0.6839 | Remote Similarity | NPC319870 |
0.6839 | Remote Similarity | NPC73078 |
0.6839 | Remote Similarity | NPC265335 |
0.6839 | Remote Similarity | NPC189724 |
0.6839 | Remote Similarity | NPC469360 |
0.6839 | Remote Similarity | NPC148738 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC282087 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD1537 | Approved |
1.0 | High Similarity | NPD1538 | Phase 1 |
1.0 | High Similarity | NPD1519 | Approved |
0.9847 | High Similarity | NPD1522 | Approved |
0.9847 | High Similarity | NPD1523 | Approved |
0.9846 | High Similarity | NPD1536 | Approved |
0.9695 | High Similarity | NPD1521 | Approved |
0.9695 | High Similarity | NPD1520 | Approved |
0.8769 | High Similarity | NPD1535 | Discovery |
0.8702 | High Similarity | NPD1481 | Phase 2 |
0.8571 | High Similarity | NPD196 | Phase 1 |
0.8456 | Intermediate Similarity | NPD2614 | Approved |
0.8308 | Intermediate Similarity | NPD9568 | Approved |
0.8264 | Intermediate Similarity | NPD2976 | Clinical (unspecified phase) |
0.8045 | Intermediate Similarity | NPD1894 | Discontinued |
0.7823 | Intermediate Similarity | NPD7596 | Clinical (unspecified phase) |
0.782 | Intermediate Similarity | NPD256 | Approved |
0.782 | Intermediate Similarity | NPD255 | Approved |
0.7748 | Intermediate Similarity | NPD3536 | Discontinued |
0.773 | Intermediate Similarity | NPD9569 | Approved |
0.7687 | Intermediate Similarity | NPD2239 | Approved |
0.7687 | Intermediate Similarity | NPD2240 | Approved |
0.7655 | Intermediate Similarity | NPD555 | Phase 2 |
0.7639 | Intermediate Similarity | NPD259 | Phase 1 |
0.7628 | Intermediate Similarity | NPD5355 | Approved |
0.7628 | Intermediate Similarity | NPD5356 | Approved |
0.7622 | Intermediate Similarity | NPD5163 | Phase 2 |
0.7603 | Intermediate Similarity | NPD3052 | Approved |
0.7603 | Intermediate Similarity | NPD3054 | Approved |
0.7548 | Intermediate Similarity | NPD3455 | Phase 2 |
0.75 | Intermediate Similarity | NPD9536 | Phase 1 |
0.75 | Intermediate Similarity | NPD9537 | Phase 1 |
0.7448 | Intermediate Similarity | NPD3056 | Clinical (unspecified phase) |
0.7397 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7397 | Intermediate Similarity | NPD5745 | Approved |
0.7379 | Intermediate Similarity | NPD3136 | Phase 2 |
0.7376 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7376 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7357 | Intermediate Similarity | NPD3847 | Discontinued |
0.7333 | Intermediate Similarity | NPD9570 | Approved |
0.7308 | Intermediate Similarity | NPD7131 | Phase 3 |
0.7296 | Intermediate Similarity | NPD4018 | Clinical (unspecified phase) |
0.7292 | Intermediate Similarity | NPD258 | Approved |
0.7292 | Intermediate Similarity | NPD257 | Approved |
0.7273 | Intermediate Similarity | NPD968 | Approved |
0.7267 | Intermediate Similarity | NPD6867 | Clinical (unspecified phase) |
0.7267 | Intermediate Similarity | NPD6866 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD5746 | Approved |
0.726 | Intermediate Similarity | NPD9718 | Approved |
0.7256 | Intermediate Similarity | NPD7608 | Discontinued |
0.7252 | Intermediate Similarity | NPD9608 | Approved |
0.7252 | Intermediate Similarity | NPD9610 | Approved |
0.725 | Intermediate Similarity | NPD3465 | Clinical (unspecified phase) |
0.7237 | Intermediate Similarity | NPD2030 | Discontinued |
0.7233 | Intermediate Similarity | NPD6677 | Suspended |
0.7233 | Intermediate Similarity | NPD2541 | Clinical (unspecified phase) |
0.723 | Intermediate Similarity | NPD826 | Approved |
0.723 | Intermediate Similarity | NPD825 | Approved |
0.7222 | Intermediate Similarity | NPD1203 | Approved |
0.7219 | Intermediate Similarity | NPD4477 | Approved |
0.7219 | Intermediate Similarity | NPD4476 | Approved |
0.7219 | Intermediate Similarity | NPD7450 | Phase 2 |
0.72 | Intermediate Similarity | NPD5688 | Approved |
0.72 | Intermediate Similarity | NPD5689 | Approved |
0.7192 | Intermediate Similarity | NPD600 | Approved |
0.7192 | Intermediate Similarity | NPD596 | Approved |
0.7179 | Intermediate Similarity | NPD5348 | Clinical (unspecified phase) |
0.7178 | Intermediate Similarity | NPD5709 | Phase 3 |
0.7172 | Intermediate Similarity | NPD558 | Phase 2 |
0.717 | Intermediate Similarity | NPD6502 | Phase 2 |
0.7169 | Intermediate Similarity | NPD3451 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD3686 | Approved |
0.7152 | Intermediate Similarity | NPD3687 | Approved |
0.7143 | Intermediate Similarity | NPD7972 | Discontinued |
0.7134 | Intermediate Similarity | NPD4666 | Phase 3 |
0.7134 | Intermediate Similarity | NPD6390 | Discontinued |
0.7134 | Intermediate Similarity | NPD4186 | Clinical (unspecified phase) |
0.7133 | Intermediate Similarity | NPD1608 | Approved |
0.7133 | Intermediate Similarity | NPD2653 | Approved |
0.7118 | Intermediate Similarity | NPD7039 | Approved |
0.7118 | Intermediate Similarity | NPD7038 | Approved |
0.7107 | Intermediate Similarity | NPD3769 | Discontinued |
0.7103 | Intermediate Similarity | NPD2797 | Approved |
0.7095 | Intermediate Similarity | NPD3374 | Clinical (unspecified phase) |
0.7095 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7095 | Intermediate Similarity | NPD6798 | Discontinued |
0.7083 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7083 | Intermediate Similarity | NPD6582 | Phase 2 |
0.708 | Intermediate Similarity | NPD5535 | Approved |
0.7073 | Intermediate Similarity | NPD6315 | Phase 2 |
0.7067 | Intermediate Similarity | NPD4618 | Approved |
0.7067 | Intermediate Similarity | NPD4622 | Approved |
0.7051 | Intermediate Similarity | NPD6667 | Approved |
0.7051 | Intermediate Similarity | NPD6666 | Approved |
0.7047 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7032 | Intermediate Similarity | NPD3400 | Discontinued |
0.7025 | Intermediate Similarity | NPD3647 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD2203 | Discontinued |
0.6993 | Remote Similarity | NPD6032 | Approved |
0.6993 | Remote Similarity | NPD2935 | Discontinued |
0.6986 | Remote Similarity | NPD1817 | Approved |
0.6986 | Remote Similarity | NPD1818 | Approved |
0.6986 | Remote Similarity | NPD1820 | Approved |
0.6986 | Remote Similarity | NPD1819 | Approved |
0.6985 | Remote Similarity | NPD9380 | Clinical (unspecified phase) |
0.6982 | Remote Similarity | NPD3909 | Discontinued |
0.6981 | Remote Similarity | NPD7427 | Discontinued |
0.698 | Remote Similarity | NPD3268 | Approved |
0.6975 | Remote Similarity | NPD8019 | Approved |
0.6968 | Remote Similarity | NPD2459 | Approved |
0.6968 | Remote Similarity | NPD2460 | Phase 3 |
0.6968 | Remote Similarity | NPD2458 | Approved |
0.6966 | Remote Similarity | NPD3676 | Clinical (unspecified phase) |
0.6966 | Remote Similarity | NPD2428 | Approved |
0.6966 | Remote Similarity | NPD2429 | Approved |
0.6954 | Remote Similarity | NPD274 | Approved |
0.6954 | Remote Similarity | NPD6355 | Discontinued |
0.6954 | Remote Similarity | NPD275 | Approved |
0.6948 | Remote Similarity | NPD7978 | Discontinued |
0.6948 | Remote Similarity | NPD5865 | Clinical (unspecified phase) |
0.6939 | Remote Similarity | NPD6584 | Phase 3 |
0.6928 | Remote Similarity | NPD6746 | Phase 2 |
0.6923 | Remote Similarity | NPD17 | Approved |
0.6923 | Remote Similarity | NPD9566 | Approved |
0.6923 | Remote Similarity | NPD2556 | Approved |
0.6923 | Remote Similarity | NPD2554 | Approved |
0.6918 | Remote Similarity | NPD3225 | Approved |
0.6918 | Remote Similarity | NPD1283 | Approved |
0.6913 | Remote Similarity | NPD6179 | Discontinued |
0.6906 | Remote Similarity | NPD1241 | Discontinued |
0.6901 | Remote Similarity | NPD1759 | Phase 1 |
0.6901 | Remote Similarity | NPD5557 | Phase 1 |
0.6899 | Remote Similarity | NPD6682 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD9717 | Approved |
0.6897 | Remote Similarity | NPD2562 | Approved |
0.6897 | Remote Similarity | NPD2561 | Approved |
0.6875 | Remote Similarity | NPD7523 | Phase 3 |
0.6871 | Remote Similarity | NPD7495 | Discontinued |
0.6871 | Remote Similarity | NPD4433 | Discontinued |
0.6867 | Remote Similarity | NPD2313 | Discontinued |
0.686 | Remote Similarity | NPD6297 | Approved |
0.6859 | Remote Similarity | NPD3060 | Approved |
0.6859 | Remote Similarity | NPD4162 | Approved |
0.6857 | Remote Similarity | NPD595 | Approved |
0.6857 | Remote Similarity | NPD9618 | Approved |
0.6857 | Remote Similarity | NPD9614 | Approved |
0.6857 | Remote Similarity | NPD593 | Approved |
0.6855 | Remote Similarity | NPD2874 | Phase 2 |
0.6853 | Remote Similarity | NPD3049 | Approved |
0.6853 | Remote Similarity | NPD6382 | Discontinued |
0.6839 | Remote Similarity | NPD6800 | Clinical (unspecified phase) |
0.6832 | Remote Similarity | NPD2370 | Clinical (unspecified phase) |
0.6831 | Remote Similarity | NPD317 | Approved |
0.6831 | Remote Similarity | NPD1758 | Phase 1 |
0.6831 | Remote Similarity | NPD318 | Approved |
0.6828 | Remote Similarity | NPD422 | Phase 1 |
0.6824 | Remote Similarity | NPD3690 | Phase 2 |
0.6824 | Remote Similarity | NPD3691 | Phase 2 |
0.6824 | Remote Similarity | NPD3366 | Approved |
0.6824 | Remote Similarity | NPD7451 | Discontinued |
0.6821 | Remote Similarity | NPD839 | Approved |
0.6821 | Remote Similarity | NPD1423 | Approved |
0.6821 | Remote Similarity | NPD840 | Approved |
0.6821 | Remote Similarity | NPD7477 | Discontinued |
0.6818 | Remote Similarity | NPD2799 | Discontinued |
0.6815 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6815 | Remote Similarity | NPD3750 | Approved |
0.6815 | Remote Similarity | NPD4110 | Phase 3 |
0.6813 | Remote Similarity | NPD2186 | Approved |
0.681 | Remote Similarity | NPD6385 | Approved |
0.681 | Remote Similarity | NPD6386 | Approved |
0.681 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.6807 | Remote Similarity | NPD955 | Approved |
0.6807 | Remote Similarity | NPD8031 | Discontinued |
0.6806 | Remote Similarity | NPD2668 | Approved |
0.6806 | Remote Similarity | NPD2667 | Approved |
0.68 | Remote Similarity | NPD6853 | Approved |
0.68 | Remote Similarity | NPD3167 | Approved |
0.68 | Remote Similarity | NPD3179 | Approved |
0.68 | Remote Similarity | NPD3166 | Approved |
0.68 | Remote Similarity | NPD3180 | Approved |
0.68 | Remote Similarity | NPD6851 | Approved |
0.68 | Remote Similarity | NPD3164 | Approved |
0.68 | Remote Similarity | NPD7095 | Approved |
0.68 | Remote Similarity | NPD3165 | Approved |
0.6797 | Remote Similarity | NPD4579 | Clinical (unspecified phase) |
0.6797 | Remote Similarity | NPD3528 | Clinical (unspecified phase) |
0.6786 | Remote Similarity | NPD594 | Approved |
0.6786 | Remote Similarity | NPD592 | Approved |
0.6786 | Remote Similarity | NPD7484 | Phase 3 |
0.6786 | Remote Similarity | NPD7485 | Phase 3 |
0.6784 | Remote Similarity | NPD6620 | Discovery |
0.6779 | Remote Similarity | NPD454 | Approved |
0.6776 | Remote Similarity | NPD3142 | Approved |
0.6776 | Remote Similarity | NPD3140 | Approved |
0.6772 | Remote Similarity | NPD2309 | Approved |
0.6765 | Remote Similarity | NPD7784 | Clinical (unspecified phase) |
0.6761 | Remote Similarity | NPD3596 | Phase 2 |
0.6759 | Remote Similarity | NPD3496 | Discontinued |
0.6757 | Remote Similarity | NPD3266 | Approved |
PubChem CID   | 7048703;5920 |
ChEMBL   | CHEMBL1544 |
ZINC   |
Molecular Weight:   | 650.79 |
ALogP:   | 2.5615 |
MLogP:   | 2.23 |
XLogP:   | 2.213 |
# Rotatable Bonds:   | 11 |
Polar Surface Area:   | 92.78 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 23 |